Literature DB >> 31034965

Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin.

Hideo Yonezawa1, Takako Osaki2, Fuhito Hojo3, Shigeru Kamiya2.   

Abstract

The human gastric pathogen Helicobacter pylori forms biofilms in vitro and in vivo. We previously demonstrated that H. pylori biofilm formation in vitro decreased its susceptibility to clarithromycin (CAM). The aim of this study was to evaluate the effects of biofilm formation on amoxicillin (AMPC) and metronidazole (MNZ) susceptibility. In addition, we assessed the influence of biofilms of CAM resistant H. pylori on CAM susceptibility. It was shown that high levels of efflux pump gene transcripts were detected in biofilm cells of all H. pylori strains used in this study. H. pylori biofilm biomass was significantly decreased compared to initial biomass after treatment with the minimum inhibitory concentration (MIC) of AMPC. Similarly, the biofilm biomass of H. pylori decreased after treatment with MIC of MNZ, although the difference was not statistically significant. However, minimum bactericidal concentrations (MBCs) of AMPC or MNZ to biofilm cells were higher than those of planktonic cells. The biofilm biomasses of all of the CAM resistant strains were significantly decreased compared to initial biomass after treatment with 2x MIC of CAM. However, the viability of the CAM treated biofilm cells with 2x MIC of CAM was not significantly reduced compared to initial cell numbers with the exception of one strain. The viability of biofilm cells of all strains was higher than that of planktonic cells after treatment with various concentrations of CAM. These results indicate that biofilm cells were more resistant to these antibiotics than planktonic cells and that the assessment of the ability to form biofilms in H. pylori is important for eradication of this microorganism.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Antibiotics susceptibility; Biofilm formation; Clarithromycin resistance; Helicobacter pylori; MBC

Mesh:

Substances:

Year:  2019        PMID: 31034965     DOI: 10.1016/j.micpath.2019.04.030

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  19 in total

1.  In vitro antibacterial activity of nimbolide against Helicobacter pylori.

Authors:  Marina R Wylie; Ian H Windham; Faith C Blum; Hannah Wu; D Scott Merrell
Journal:  J Ethnopharmacol       Date:  2021-11-09       Impact factor: 4.360

Review 2.  Are pro- and/or synbiotics beneficial in Helicobacter pylori eradication therapy in children? A narrative review.

Authors:  Sari Daelemans; Virginie Deseck; Elvira Ingrid Levy; Yvan Vandenplas
Journal:  Eur J Pediatr       Date:  2022-06-21       Impact factor: 3.860

3.  Helicobacter pylori Biofilm Confers Antibiotic Tolerance in Part via A Protein-Dependent Mechanism.

Authors:  Skander Hathroubi; Julia Zerebinski; Aaron Clarke; Karen M Ottemann
Journal:  Antibiotics (Basel)       Date:  2020-06-24

4.  Re-Potentiation of β-Lactam Antibiotic by Synergistic Combination with Biogenic Copper Oxide Nanocubes against Biofilm Forming Multidrug-Resistant Bacteria.

Authors:  Ruby Celsia Arul Selvaraj; Mala Rajendran; Hari Prasath Nagaiah
Journal:  Molecules       Date:  2019-08-22       Impact factor: 4.411

5.  Genetic and Transcriptomic Variations for Amoxicillin Resistance in Helicobacter pylori under Cryopreservation.

Authors:  Xiurui Han; Yiyao Zhang; Lihua He; Ruyue Fan; Lu Sun; Dongjie Fan; Yanan Gong; Xiaoli Chen; Yuanhai You; Fei Zhao; Maojun Zhang; Jianzhong Zhang
Journal:  Pathogens       Date:  2021-05-30

6.  The penicillin binding protein 1A of Helicobacter pylori, its amoxicillin binding site and access routes.

Authors:  Bahareh Attaran; Najmeh Salehi; Bahareh Ghadiri; Maryam Esmaeili; Shadi Kalateh; Mohammad Tashakoripour; Mahmoud Eshagh Hosseini; Marjan Mohammadi
Journal:  Gut Pathog       Date:  2021-06-28       Impact factor: 4.181

Review 7.  Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy.

Authors:  Jianfu Ji; Hong Yang
Journal:  Int J Mol Sci       Date:  2020-02-08       Impact factor: 5.923

8.  Sulfenate Esters of Simple Phenols Exhibit Enhanced Activity against Biofilms.

Authors:  Danica J Walsh; Tom Livinghouse; Greg M Durling; Yenny Chase-Bayless; Adrienne D Arnold; Philip S Stewart
Journal:  ACS Omega       Date:  2020-03-13

Review 9.  Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets.

Authors:  Paula Roszczenko-Jasińska; Marta Ilona Wojtyś; Elżbieta K Jagusztyn-Krynicka
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-14       Impact factor: 4.813

10.  Genetic requirements and transcriptomics of Helicobacter pylori biofilm formation on abiotic and biotic surfaces.

Authors:  Skander Hathroubi; Shuai Hu; Karen M Ottemann
Journal:  NPJ Biofilms Microbiomes       Date:  2020-11-27       Impact factor: 7.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.